Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 9 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, April 22, 2026 –…
NETRIS Pharma: Nature publishes positive pancreatic cancer Phase 1b data for NP137 anti-netrin-1 monoclonal antibody
LAPNET-01 Phase 1b study shows netrin-1 blockade may overcome and prevent chemoresistance in patients with pancreatic ductal adenocarcinoma (PDAC) with locally advanced PDAC (LAPC) NP137 is the first-in-class anti-netrin-1 monoclonal antibody (mAb)…
Should You Forget Pfizer and Buy This Pharma Stock Instead?
Pfizer (PFE 1.68%) and AbbVie (ABBV 1.20%) are two pharmaceutical giants that seem to be headed in opposite directions. Pfizer's stock is up by more than 10% this year, while AbbVie's shares have fallen more than 7%. But when you look at their…
Pharma giant AbbVie plans $1.4 billion campus near Research Triangle Park
AbbVie, a biopharmaceutical giant, will invest $1.4 billion into a new facility in Durham, the company and the N.C. Department of Commerce announced Wednesday. Why it matters: The expansion is yet another win from the pharmaceutical industry for…
Amazon Targets the GLP-1 Gap Big Pharma Left Open
Amazon built one system to handle all of it. Through its One Medical arm, the company launched a GLP-1 Management Program bundling clinical screening, prescriptions, ongoing supervision and pharmacy delivery into a single offering. The program…
3 Air Quality Myths Costing Your Lab Money And Safety
Air quality in life science labs isn't the kind of topic that grabs headlines. It can't compete with breakthrough Alzheimer's treatments or the next‑generation immunotherapies transforming oncology and yet, it's what they hinge on. Behind…
Santhera Appoints Orlando Oliveira as Chief Executive Officer
Ad hoc announcement pursuant to Art. 53 LR. Dario Eklund to hand over leadership following planned transition Pratteln, Switzerland, April 23, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces the appointment of Orlando Oliveira as Chief…
Using AI To Personalize Healthcare-Without Losing Patient Trust
In this week's edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize healthcare and speed up clinical trials, the future of genetic medicine, another big Lilly acquisition, and more. To get it in your…
Inhibrx: Spinoff Rumors Send Shares Soaring - Stunning Bull Run Can Continue (NASDAQ:INBX)
Inhibrx Biosciences, Inc. has surged nearly 40% amid rumors of Big Pharma interest in joint spinoffs of INBRX-106 and possibly a second asset. Ozekibart's Phase 2 data in chondrosarcoma showed a 52% risk reduction in progression or death…
Nifty Prediction Today - April 23, 2026: Nifty futures: Steadies after gap-down open, support can help in recovery
Nifty 50 began today's session with a gap-down at 24,202 compared to yesterday's close of 24,378. But the index recouped some of its losses and at the end of the first hour, it is trading at 24,260, down 0.4 per cent. The advance/decline ratio…
Elkedonia strengthens Board of Directors with appointment of Pierre d'Epenoux as Independent Chairman
Appointment strengthens Elkedonia's governance as the company continues its development and prepares for its next phases of growth Pierre d'Epenoux is former CEO of ImCheck Therapeutics, a clinical-stage biotech immuno-oncology company acquired by…
Stock markets slump in early trade as crude oil prices jump over $100 per barrel mark
Equity benchmark indices Sensex and Nifty tumbled in early trade on Thursday (April 23, 2026) as crude oil prices once again breached the $100 per barrel mark amid stalled U.S.–Iran negotiations. Foreign fund outflows and weak trends in…
Cardinal Health (CAH) Q1 2025 Earnings Transcript
Friday, November 1, 2024 at 8:30 a.m. ET Chief Executive Officer — Jason Hollar Chief Financial Officer — Aaron Alt Revenue -- $52 billion, down 4%, reflecting the large customer transition; revenue rose 15% excluding this impact.
Progyny: Significant Non-Cash Compensation Limits Value Case (NASDAQ:PGNY)
Progyny offers exposure to secular fertility trends but operates as a middleman, which limits its value-add versus direct service providers. Headline valuation appears attractive with a sub-10x PE and 13.5% FCFY, but significant stock-based…
Prediction: Investors Rotating Out of Artificial Intelligence (AI) Stocks Made a Costly Mistake. The Nasdaq Proves It.
Over the past three years, artificial intelligence (AI) stocks have been the engine driving the stock market higher. Of course, many stocks across industries also gained, but AI stocks offered the biggest push. And for a good reason: AI has the…
Receive a Daily briefing on Pharma Industry News
Get Started